Skip to main content
Premium Trial:

Request an Annual Quote

Stemina Receives $2.7M NIH Grant for Study of Metabolic Autism Biomarkers

NEW YORK (GenomeWeb) — Stemina Biomarker Discovery announced today that it has initiated a clinical study examining metabolism biomarkers for autism spectrum disorder (ASD) with the support of a $2.7 million grant from the National Institutes of Health.

Also funding the study is a $2.3 million investment from the Nancy Lurie Marks Family Foundation that Stemina received last year.

The trial, dubbed the Children's Autism Metabolome Project (CAMP), will enroll 1,500 subjects at six sites across the US with the goal of confirming that previously identified metabolic biomarkers can detect subtypes of ASD. Study participants will include children with autism, children without autism but with other neurodevelopmental disorders, and normally developing children.

CAMP builds on three pilot studies previously conducted in more than 500 children and is also designed to identify new biomarkers that may enable earlier diagnosis and better treatment of ASD. In preliminary studies, the company was able to distinguish patients with autism from typically developing children with 81 percent accuracy.

"Confirmation of findings from our previous … pilot studies would be an important step toward developing an early diagnostic marker of ASD," David Amaral, a researcher at the University of California, Davis, and Stemina collaborator, said in a statement.

"By diagnosing ASD based on the patient’s metabolism, we hope to understand what is different about the metabolism of children with ASD and each subtype compared to typically developing children," Stemina CEO Elizabeth Donley added. "This approach will open up a whole new frontier for understanding the disorder and how to treat it."

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.